Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$234M |
| 2 |
Jones Lang LaSalle
JLL
|
+$172M |
| 3 |
CANO
Cano Health, Inc.
CANO
|
+$113M |
| 4 |
Carvana
CVNA
|
+$84.7M |
| 5 |
IS
ironSource Ltd.
IS
|
+$64.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$89.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$73.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$73.3M |
| 4 |
Lam Research
LRCX
|
+$73M |
| 5 |
Amazon
AMZN
|
+$71.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 52.76% |
| 2 | Healthcare | 15.32% |
| 3 | Technology | 11.25% |
| 4 | Communication Services | 7.75% |
| 5 | Financials | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Canadian National Railway
CNI
$78.5B
| – | – |
-153
| Closed | -$18K |
|
702
ConocoPhillips
COP
$162B
| – | – |
-1,261
| Closed | -$67K |
|
703
Copa Holdings
CPA
$5.88B
| – | – |
-558
| Closed | -$45K |
|
704
Capri Holdings
CPRI
$1.55B
| – | – |
-47,645
| Closed | -$2.43M |
|
705
Carter's
CRI
$1.31B
| – | – |
-22,042
| Closed | -$1.96M |
|
706
Cerence
CRNC
$365M
| – | – |
-621
| Closed | -$56K |
|
707
CrowdStrike
CRWD
$195B
| – | – |
-35,988
| Closed | -$1.64M |
|
708
CVS Health
CVS
$119B
| – | – |
-11,556
| Closed | -$869K |
|
709
DoorDash
DASH
$96.8B
| – | – |
-81,393
| Closed | -$10.3M |
|
710
Donaldson
DCI
$10.8B
| – | – |
-2,383
| Closed | -$139K |
|
711
3D Systems Corp
DDD
$530M
| – | – |
-2,472
| Closed | -$68K |
|
712
Diageo
DEO
$52.6B
| – | – |
-12,140
| Closed | -$1.99M |
|
|
DFS
713
DELISTED
Discover Financial Services
DFS
| – | – |
-281
| Closed | -$27K |
|
714
Quest Diagnostics
DGX
$27B
| – | – |
-2,441
| Closed | -$313K |
|
715
Walt Disney
DIS
$186B
| – | – |
-8,934
| Closed | -$1.65M |
|
716
Dynatrace
DT
$14.2B
| – | – |
-7,123
| Closed | -$344K |
|
717
DTE Energy
DTE
$28.1B
| – | – |
-748
| Closed | -$85K |
|
718
Ecolab
ECL
$78.9B
| – | – |
-936
| Closed | -$200K |
|
719
Encore Capital Group
ECPG
$2.15B
| – | – |
-6,849
| Closed | -$276K |
|
720
Consolidated Edison
ED
$39.3B
| – | – |
-2,324
| Closed | -$174K |
|
721
Editas Medicine
EDIT
$478M
| – | – |
-331
| Closed | -$14K |
|
722
Edison International
EIX
$27.5B
| – | – |
-1,144
| Closed | -$67K |
|
723
Elanco Animal Health
ELAN
$12B
| – | – |
-1,717,913
| Closed | -$50.6M |
|
724
Enbridge
ENB
$110B
| – | – |
-22,439
| Closed | -$817K |
|
725
Enovis
ENOV
$1.5B
| – | – |
-7,756
| Closed | -$585K |
|
Similar funds
Lee Ainslie's Q2 2021 Portfolio in Review
As of Q2 2021, Lee Ainslie held 915 positions worth $10.6B, down 1.9% from $10.9B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Lee Ainslie's Q2 2021 filing shows 227 new, 218 increased, 210 reduced and 254 closed positions. Its largest new stake was Centene: 3,416,815 shares worth $249M. The largest sale was Applied Materials, an estimated $89.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, down from 55% a quarter earlier, followed by Healthcare and Technology.
- Lee Ainslie's largest Q2 2021 buy was Centene: 3,416,815 shares worth $249M.
- Lee Ainslie added most to Carvana in Q2 2021, an estimated $84.7M increase.
- Lee Ainslie's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $89.8M.
- Lee Ainslie fully exited Fidelity National Information Services in Q2 2021, selling an estimated $63.1M.
- Lee Ainslie's ten largest holdings make up 60% of its $10.6B portfolio in Q2 2021.
- Lee Ainslie opened 227 new positions and closed 254 in Q2 2021.
- Lee Ainslie's portfolio value fell 1.9% quarter-over-quarter to $10.6B.
Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.